Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00341211 · ClinicalTrials.gov registry record
Specimens From Normal Controls
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 27
- Enrollment target
NCT00341211: Completed study, sponsored by National Cancer Institute (NCI).
NCT00341211 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00341211 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For some research questions, specimens are available from "case" subjects as part of ongoing protocols but are not available from normal "control" subjects (i.e., those without the infection or disease under study) to whom the case subjects can be compared. This protocol is to obtain routine specimens (usually peripheral venous blood, occasionally other body fluid such as saliva, urine, or tears) from healthy volunteers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 1996-04-11 |
| Est. Completion | 2010-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00341211
The ClinicalTrials.gov registry entry for NCT00341211 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00341211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00341211 about?
NCT00341211 is a clinical study titled "Specimens From Normal Controls". The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For some research questions, specimens are available from "case" subjects as part of ongoing protocols but are not ...
What is the current status of trial NCT00341211?
This trial is currently completed. The enrollment target is 27 participants. The study started on 1996-04-11. Estimated completion is 2010-12-01.
Who is sponsoring clinical trial NCT00341211?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.